UCB partners with Ariceum for treatment of immune-related diseases and cancer

UCB partners with Ariceum for treatment of immune-related diseases and cancer

Source: 
Biopharma Reporter
snippet: 

UCB and Ariceum have announced a strategic research collaboration to identify and develop systemic targeted radiopharmaceuticals for the treatment of solid tumors and immune-related diseases.